Gaudium IVF IPO Details
| IPO Open Date | February 20, 2026 |
| IPO Close Date | February 24, 2026 |
| Face Value | â‚ą5 Per Equity Share |
| IPO Price Band | â‚ą75 to â‚ą79 Per Share |
| Issue Size | Approx â‚ą165 Crores |
| Fresh Issue | Approx â‚ą90 Crores |
| Offer for Sale: | Approx 94,93,700 Equity Shares |
| Issue Type | Book build Issue |
| IPO Listing | BSE, NSE |
| DRHP Draft Prospectus |  |
| RHP Draft Prospectus | |
Gaudium IVF IPO Review & Key Points
- Review: Neutral
Gaudium IVF IPO Market Lot
The Gaudium IVF IPO minimum market lot is 189 shares with â‚ą14,931 application amount. The retail investors can apply up to 13 lots with 2,457 shares of â‚ą1,94,103 amount.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 1 | 189 | â‚ą14,931 |
| Retail Maximum | 13 | 2,457 | â‚ą1,94,103 |
| S-HNI Minimum | 14 | 2,646 | â‚ą2,09,034 |
| S-HNI Maximum | 66 | 12,474 | â‚ą9,85,446 |
| B-HNI Minimum | 67 | 12,663 | â‚ą10,00,377 |
IPO Reservation
| Investor Category | Share Offered | Shares (%) |
| Anchor Investor | 62,65,860 Shares | 30% |
| QIB (Ex. Anchor) | 41,77,240 Shares | 20% |
| NII Shares Offered | 31,32,930 Shares | 15% |
| Retail Shares Offered | 73,10,170 Shares | 35% |
Gaudium IVF IPO Anchor Investors
| Anchor Bidding Date | February 19, 2026 |
| Anchor Investors List | |
| Shares Offered | 62,65,860 Shares |
| Anchor Size | 49.50 Cr. |
| lock-in period end date 50% shares (30 Days) | March 27, 2026 |
| lock-in period end date 50% shares (90 Days) | May 26, 2026 |
Gaudium IVF IPO Dates
The Gaudium IVF IPO date is February 20, and the close date is February 24. The Gaudium IVF IPO allotment will be finalized on February 2,5 and the IPO listing on February 27.
| IPO Open Date: | February 20, 2026 |
| IPO Close Date: | February 24, 2026 |
| Basis of Allotment: | February 25, 2026 |
| Refunds: | February 26, 2026 |
| Credit to Demat Account: | February 26, 2026 |
| IPO Listing Date: | February 27, 2026 |
| IPO Bidding Cut-off Time: | February 24, 2026 – 5 PM |
Promoters and Holding Pattern
The promoters of the company are Dr. Manika Khanna, Dr. Peeyush Khanna and Vishad Khanna.
| Particular | Shares | % Share |
| Promoter Holding Pre Issue | 6,13,94,384 | 99.99% |
| Promoter Holding Post Issue | 7,27,86,884 | 71.30% |
Objects of the Issue & Utilisation of Proceeds
| Purpose | Crores |
Funding capital expenditure towards establishment of New IVF Centers of the Company | â‚ą50 |
| Repayment/pre-payment, in full or in part, of certain outstanding loans availed by our Company; and | â‚ą20 |
| General Corporate Purpose | â‚ą- |
About Gaudium IVF IPO
Gaudium IVF, founded in March 2015, is one of the leading companies offering In Vitro Fertilization (IVF) treatments for women across India. The company operates its business over 30 locations, with seven hubs (centres) and twenty-eight spokes. The firm treats its patients in various countries, including Canada, the United Kingdom, the United States, Kenya, South Africa, and Oman.
The firm offers various fertility services such as Vitro Fertilisation (IVF), intracytoplasmic sperm injection (ICSI), intrauterine insemination (IUI), and ovulation induction. Its treatments are targeted towards both genders. Moreover, the firm also provides PCOD/PCOS, endometriosis, and special care for women in pregnancy with complex fertility issues. Gaudium IVF also offers treatments targeting male infertility, including advanced sperm retrieval procedures.
Gaudium IVF IPO Company Financial Report
Amount â‚ą in Crores
| Period Ended | Revenue | Expense | PAT | Assets |
| 2023 | â‚ą44.26 | â‚ą25.95 | â‚ą13.53 | â‚ą36.63 |
| 2024 | â‚ą48.15 | â‚ą31.52 | â‚ą10.32 | â‚ą51.01 |
| 2025 | â‚ą70.96 | â‚ą45.54 | â‚ą19.13 | â‚ą88.51 |
| Sep 2025 | â‚ą49.75 | â‚ą32.97 | â‚ą12.51 | â‚ą106.62 |
Gaudium IVF IPO Valuation – FY2025
Check Gaudium IVF IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
| KPI | Values |
| ROE: | 41.31% |
| ROCE: | 39.70% |
| EBITDA Margin: | 40.48% |
| PAT Margin: | 26.96% |
| Debt to equity ratio: | 0.41 |
| Earning Per Share (EPS): | â‚ą3.12 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 41.71% |
| Net Asset Value (NAV): | â‚ą7.54 |
Peer Group Comparison
- There are no listed industry peers available.
IPO Lead Managers aka Merchant Bankers
- Sarthi Capital Advisors Pvt. Ltd.
Company Address
Gaudium IVF & Women’s Health Ltd.
B1/51,
Janak Puri,
B-1,
New Delhi, New Delhi, 110058
Phone: 011-4885 8585
Email: [email protected]
Website: https://www.gaudiumivfcentre.com/
IPO Registrar
Bigshare Services Pvt. Ltd.
Phone: +91-22-6263 8200
Email: [email protected]
Website: https://ipo.bigshareonline.com/IPO_Status.html
Gaudium IVF IPO FAQs
What is Gaudium IVF IPO?
When Gaudium IVF IPO will open for subscription?
What is Gaudium IVF IPO Investors Portion?
How to Apply the Gaudium IVF IPO?
What is Gaudium IVF IPO Issue Size?
What is Gaudium IVF IPO Price Band?
What is Gaudium IVF IPO Lot Size?
What is the Gaudium IVF IPO Allotment Date?
What is the Gaudium IVF IPO Listing Date?
Note: The Gaudium IVF IPO price band and date are officially announced. The (Gaudium IVF IPO grey market premium) will be added to the IPO GMP page as it will start).
2 Responses
I am already invested in this IPO can u suggest me proper percentage of listing premium
Superb